Finally, in distinct experimental paradigms, including the MS murine model experimental autoimmune encephalomyelitis (EAE), the systemic administration of MDP was shown to foster immune tolerance via the activation of NOD2 in myeloid cells [50,51,52,53]. Here, NOD2 is linked to experimental autoimmune encephalomyelitis.